• Yatin Mehta, Dhruva Chaudhry, O C Abraham, Jose Chacko, Jigeeshu Divatia, Bharat Jagiasi, Arindam Kar, G C Khilnani, Bhuvana Krishna, Prashant Kumar, R K Mani, B K Rao, Pawan K Singh, Sanjeev Singh, Pavan Tiwary, Chand Wattal, Deepak Govil, Subhal Dixit, and Srinivas Samavedam.
• Department of Critical Care and Anesthesiology, Medanta: The Medicity, Gurugram, Haryana, India.
• Indian J Crit Care Med. 2020 Nov 1; 24 (Suppl 5): S225-S230.

AbstractThe management of coronavirus disease-2019 (COVID-19) is witnessing a change as we learn more about the pathophysiology and the severity of the disease. Several randomized controlled trials (RCTs) and meta-analysis have been published over the last few months. Several interventions and therapies which showed promise in the initial days of the pandemic have subsequently failed to show benefit in well-designed trials. Understanding of the methods of oxygen delivery and ventilation have also evolved over the past few months. The Indian Society of Critical Care Medicine (ISCCM) has reviewed the evidence that has emerged since the publication of its position statement in May and has put together an addendum of updated evidence. How to cite this article: Mehta Y, Chaudhry D, Abraham OC, Chacko J, Divatia J, Jagiasi B, et al. Critical Care for COVID-19 Affected Patients: Position Statement of the Indian Society of Critical Care Medicine. Indian J Crit Care Med 2020;24(Suppl 5):S225-S230.Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd.

3 keywords...

hide…